Taizhou Mabtech Pharmaceutical Co.,ltd
Clinical trials sponsored by Taizhou Mabtech Pharmaceutical Co.,ltd, explained in plain language.
-
New psoriasis drug shows promise in Head-to-Head trial
Disease control CompletedThis study tested whether a new drug, CMAB015, works as well as the approved drug secukinumab for people with moderate to severe plaque psoriasis. 336 adults received injections of either drug over 48 weeks. The main goal was to see if at least 75% of their skin cleared up after …
Phase: PHASE3 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Healthy men help compare new allergy drug to standard treatment
Knowledge-focused CompletedThis study tested a new version of the allergy drug omalizumab (called CMAB007) against the approved drug Xolair. It involved 114 healthy Chinese men aged 18 to 45. The goal was to see how the body absorbs and processes each drug and to check for any side effects. This is an earl…
Phase: PHASE1 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated May 17, 2026 03:27 UTC